Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

5.9%

1 terminated out of 17 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

47%

8 trials in Phase 3/4

Results Transparency

50%

7 of 14 completed with results

Key Signals

7 with results93% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (1)
P 1 (1)
P 2 (4)
P 3 (6)
P 4 (2)

Trial Status

Completed14
Recruiting1
Terminated1
Unknown1

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT02979951Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

NCT02925416Phase 4CompletedPrimary

Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection

NCT03747497Phase 2CompletedPrimary

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

NCT04485676CompletedPrimary

Dalbavancin in Real Clinical Practice in Spain

NCT00761215Phase 2Completed

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

NCT01619410Not ApplicableTerminatedPrimary

Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections

NCT02276482Phase 3Completed

Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)

NCT00948142Phase 2CompletedPrimary

Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections

NCT02477514Phase 1CompletedPrimary

A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004)

NCT00997997CompletedPrimary

Avelox in Complicated Skin and Skin Structure Infections

NCT00488345Phase 2Completed

Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age

NCT00368537Phase 4CompletedPrimary

Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

NCT00210899Phase 3Completed

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

NCT00228982Phase 3Completed

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

NCT00249197Phase 3CompletedPrimary

A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections

NCT01369251Phase 3Unknown

Simple Hygiene Versus Alcohol Based Usual Care for Umbilical Cord

NCT00303550Phase 3CompletedPrimary

Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)

Showing all 17 trials

Research Network

Activity Timeline